December 9, 2022 /

Webinar: A Conversation with PTC Therapeutics (December 2022)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

PTC Therapeutics joined PPMD for a community webinar on December 9, 2022 for a discussion regarding PTC’s history with the community and plans for the future, including activities to bring ataluren (Translarna) to US patients with nonsense mutations.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo